Menu
GeneBe

PDE5A

phosphodiesterase 5A, the group of Phosphodiesterases

Basic information

Region (hg38): 4:119494396-119628804

Links

ENSG00000138735NCBI:8654OMIM:603310HGNC:8784Uniprot:O76074AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PDE5A gene.

  • Inborn genetic diseases (17 variants)
  • not provided (15 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDE5A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
4
clinvar
8
missense
16
clinvar
3
clinvar
3
clinvar
22
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
2
2
non coding
0
Total 0 0 16 7 7

Variants in PDE5A

This is a list of pathogenic ClinVar variants found in the PDE5A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-119498633-T-C not specified Uncertain significance (May 22, 2023)2511000
4-119501164-A-AAAT Benign (Jun 08, 2018)722286
4-119501236-C-T Benign (Jun 13, 2018)786047
4-119502583-T-A not specified Uncertain significance (Jan 31, 2024)3210748
4-119502607-T-G Benign (Mar 01, 2018)719486
4-119502610-C-T not specified Uncertain significance (Aug 30, 2021)2247214
4-119502636-G-C not specified Likely benign (Aug 12, 2021)2376966
4-119502654-A-G Likely benign (Jun 16, 2018)779419
4-119504547-T-C not specified Uncertain significance (Jun 30, 2022)2398246
4-119505903-C-T Likely benign (Jul 10, 2018)708681
4-119505936-C-T Benign (Feb 09, 2018)777148
4-119511122-T-G Benign (Apr 10, 2018)789729
4-119511125-A-G Likely benign (Apr 01, 2022)2655054
4-119519083-A-G Likely benign (Jul 17, 2018)760312
4-119519102-A-G not specified Uncertain significance (Jan 08, 2024)3210747
4-119519123-A-G Benign (Jan 19, 2018)729052
4-119521050-C-T not specified Uncertain significance (Nov 01, 2022)2321662
4-119525571-T-C not specified Uncertain significance (Jun 13, 2022)2295453
4-119542576-G-T not specified Uncertain significance (Jan 09, 2024)3210746
4-119542593-T-G Benign (Feb 08, 2018)724466
4-119542606-C-T Benign/Likely benign (Feb 01, 2024)779420
4-119542623-G-T not specified Uncertain significance (May 04, 2022)2287193
4-119552585-G-A not specified Uncertain significance (Aug 10, 2023)2617729
4-119552613-G-C not specified Uncertain significance (Dec 01, 2022)2331180
4-119552622-T-C not specified Uncertain significance (Dec 26, 2023)3210744

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PDE5Aprotein_codingprotein_codingENST00000354960 21134597
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0001061.001257010471257480.000187
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.103274530.7220.00002245828
Missense in Polyphen96169.630.565952206
Synonymous1.331361570.8650.000007771532
Loss of Function4.251647.60.3360.00000235588

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004890.000460
Ashkenazi Jewish0.0001990.000198
East Asian0.0001630.000163
Finnish0.0002320.000231
European (Non-Finnish)0.0002160.000211
Middle Eastern0.0001630.000163
South Asian0.0001130.0000980
Other0.0003270.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. This phosphodiesterase catalyzes the specific hydrolysis of cGMP to 5'- GMP (PubMed:9714779, PubMed:15489334). Specifically regulates nitric-oxide-generated cGMP (PubMed:15489334). {ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9714779}.;
Pathway
Purine metabolism - Homo sapiens (human);cGMP-PKG signaling pathway - Homo sapiens (human);Phosphodiesterases in neuronal function;Purine nucleotides nucleosides metabolism;Hemostasis;cGMP effects;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis (Consensus)

Recessive Scores

pRec
0.238

Intolerance Scores

loftool
0.457
rvis_EVS
1.05
rvis_percentile_EVS
91.34

Haploinsufficiency Scores

pHI
0.178
hipred
Y
hipred_score
0.641
ghis
0.475

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.443

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pde5a
Phenotype

Gene ontology

Biological process
signal transduction;positive regulation of cardiac muscle hypertrophy;regulation of nitric oxide mediated signal transduction;negative regulation of T cell proliferation;positive regulation of MAP kinase activity;cGMP catabolic process;negative regulation of cardiac muscle contraction;relaxation of cardiac muscle;positive regulation of oocyte development
Cellular component
cellular_component;cytosol
Molecular function
3',5'-cyclic-nucleotide phosphodiesterase activity;protein binding;cGMP binding;metal ion binding;3',5'-cyclic-GMP phosphodiesterase activity